(Q37118786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Lymphocyte-derived cytokines in inflammatory arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Nicole Horwood

series ordinal

1

1 reference

18 August 2017

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

230-238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

The role of T lymphocytes in bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Epidemiology of osteoporosis in rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Anti-TNF therapy: where have we got to in 2005?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

The role of T cells in rheumatoid arthritis: new subsets and new targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Cartilage breakdown in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Amelioration of arthritis in two murine models using antibodies to oncostatin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Interleukin-6: a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694766

10.1080/08916930701694766

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18365837%20AND%20SRC:MED&resulttype=core&format=json

release_rk54xumovbafxgadsngmgoq2n4

4 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rk54xumovbafxgadsngmgoq2n4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference